Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

BackgroundImmune checkpoint inhibition, combined with novel biomarkers, may provide alternative pathways for treating chemotherapy-resistant triple-negative breast cancer (TNBC). This study investigates the expression of new immune checkpoint receptors, including CD155 and CD73, which play a role in...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Neslihan Cabioglu, Aysel Bayram, Selman Emiroglu, Semen Onder, Huseyin Karatay, Gizem Oner, Mustafa Tukenmez, Mahmut Muslumanoglu, Abdullah Igci, Adnan Aydiner, Pinar Saip, Ekrem Yavuz, Vahit Ozmen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-07-01
Edice:	Frontiers in Oncology
Témata:	CD155 CD73 chemotherapy response prognosis triple-negative breast cancer
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1165257/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!